Elly Barry

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer chemotherapy and pharmacology

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Drew W Rasco, Theresa Medina, Pippa Corrie, Anna C Pavlick, Mark R Middleton, Paul Lorigan, Chris Hebert, Ruth Plummer, James Larkin, Sanjiv S Agarwala, Adil I Daud, Jiaheng Qiu, Viviana Bozon, Michelle Kneissl, Elly Barry, Anthony J Olszanski
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma. Cancer chemotherapy and pharmacology (2023)
Bram De Wilde, Elly Barry, Elizabeth Fox, Dominik Karres, Mark W Kieran, John Manlay, Donna Ludwinski, Gregory H Reaman, Pamela R Kearns
The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Joanna C Masters, Elly Barry, Beverly Knight
Population Pharmacokinetics of Gemtuzumab Ozogamicin in Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia. Clinical pharmacokinetics 58 (2) (2020)